University research centres / Academic / Research, Biotechnology – Therapeutics
Falco Biotherapeutics is a privately held biopharmaceutical company, focused on the development of ElCams™. ElCams™ are a new generation of novel therapeutic, diagnostic and prophylactic protein-based health care products. They are designed to satisfy unmet patient needs and to improve medical practice. ElCams™ are based on our proprietary affinity technology which allows us to create low molecular weight proteins, that combine the selectivity and affinity of monoclonal antibodies with advantages of small molecules drugs.
More information about Falco Bio Therapeutics »
Biotechnology – Therapeutics